Title | Program description | Type | Credit | Event date |
---|---|---|---|---|
Unique Considerations in Pediatric Tuberculosis - 7:00 a.m. Central Time |
September 13, 2024 - Webinar - Broadcast in Central Time This session will delve into the distinct characteristics of tuberculosis (TB) in children compared to adults. Participants will examine variations in TB occurrence, risk factors, and how the disease manifests in young patients. The session will also address the differences in diagnosing TB in children, including interpreting chest X-rays and utilizing tests like IGRAs. Finally, the discussion will focus on the unique factors to consider when treating TB in children, covering both latent infection and active disease. |
Live |
|
09/13/2024 |
Unique Considerations in Pediatric Tuberculosis - 12:00 p.m. Central Time |
September 13, 2024 - Webinar - Broadcast in Central Time This session will delve into the distinct characteristics of tuberculosis (TB) in children compared to adults. Participants will examine variations in TB occurrence, risk factors, and how the disease manifests in young patients. The session will also address the differences in diagnosing TB in children, including interpreting chest X-rays and utilizing tests like IGRAs. Finally, the discussion will focus on the unique factors to consider when treating TB in children, covering both latent infection and active disease. |
Live |
|
09/13/2024 |
Emerging Infections in Clinical Practice and Public Health 2024 |
November 22, 2024 - InterContinental Minneapolis-St. Paul Airport - St. Paul, Minnesota This course offers Live (in-person) attendance. Preventing, controlling and treating emerging infections continue to be an essential focus for clinicians, infection control and public health practitioners, and laboratorians. This continuing education conference in its 30th year, provides a forum for authoritative presentations and discussions on the epidemiology, prevention and control of emerging infectious diseases. Topics include the new RSV vaccines and treatments, antibiotic resistance in Candida auris, and the emerging field of phage therapy for antibiotic resistant infections. |
Live |
|
11/22/2024 |